Primary Hyperaldosteronism: Endocrine Society Guidelines
Primary hyperaldosteronism (PA) is a common cause of secondary hypertension, and timely diagnosis and treatment are important for preventing end-organ damage. The Endocrine Society has published guidelines on the diagnosis and management of PA, which are essential for healthcare providers involved in the care of patients with hypertension. This question bank is designed to aid physicians in preparing for exams and in clinical practice, by providing a comprehensive review of the key concepts and practical applications of the Endocrine Society's guidelines for PA management. This question bank is an essential resource for healthcare providers looking to stay up-to-date on the latest evidence-based recommendations for managing PA.
